Patents by Inventor Alan Grubbs

Alan Grubbs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230264164
    Abstract: Nucleic acid memory strands encoding digital data using a sequence of a homopolymer tracts of repeated nucleotides provides a cheaper and faster alternative to conventional digital DNA storage techniques. The use of homopolymer tracts allows for lower fidelity, high throughput sequencing techniques such as nanopore sequencing to read data encoded in the memory strands. Specialized synthesis techniques allow for synthesis of long memory strands capable of encoding large volumes of data despite the reduced data density afforded by homopolymer tracts as compared to conventional single nucleotide sequences.
    Type: Application
    Filed: March 27, 2023
    Publication date: August 24, 2023
    Inventors: J. William Efcavitch, Sanjay Agarwalla, Kim Albizati, Alan Grubbs, Matthew Holden, Patrycja Hopkins, Jay Singh
  • Publication number: 20230108594
    Abstract: The present invention provides synthesis, pharmaceutically acceptable formulations and uses of compounds in accordance with Formula I, or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof. For Formula I compounds X1, X2, X3, X4, X5, X6, Q, L1, L2, Y, R1, R2, R3, R4, R5, R6, R7, R8 and rings A, B and C are as defined in the specification. The inventive Formula I compounds are inhibitors of eIF4e and find utility in any number of therapeutic applications, including but not limited to treatment of inflammation and various cancers.
    Type: Application
    Filed: January 28, 2022
    Publication date: April 6, 2023
    Inventors: Samuel SPERRY, Alan X. XIANG, Justin T. ERNST, Siegfried H. REICH, Paul A. SPRENGELER, Mike SHAGHAFI, Theo Michels, Christian NILEWSKI, Chinh Viet TRAN, Garrick Kenneth PACKARD, Alan GRUBBS, Kaveri URKALAN, Takasuke MUKAIYAMA
  • Patent number: 11286268
    Abstract: The present invention provides synthesis, pharmaceutically acceptable formulations and uses of compounds in accordance with Formula I, or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof. For Formula I compounds X1, X2, X3, X4, X5, X6, Q, L1, L2, Y, R1, R2, R3, R4, R5, R6, R7, R8 and rings A, B and C are as defined in the specification. The inventive Formula I compounds are inhibitors of eIF4e and find utility in any number of therapeutic applications, including but not limited to treatment of inflammation and various cancers.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: March 29, 2022
    Assignee: eFFECTOR Therapeutics, Inc.
    Inventors: Samuel Sperry, Alan X. Xiang, Justin T. Ernst, Siegfried H. Reich, Paul A. Sprengeler, Mike Shaghafi, Theo Michels, Christian Nilewski, Chinh Viet Tran, Garrick Kenneth Packard, Alan Grubbs, Kaveri Urkalan, Takasuke Mukaiyama
  • Patent number: 10619098
    Abstract: Compounds that have ultraviolet light absorbing properties, and which can also have mesogenic properties. Compositions that include one or more such compounds. Articles of manufacture that include one or more such compounds, such as optical elements that include an optical substrate and a layer that includes at least one such compound.
    Type: Grant
    Filed: September 21, 2015
    Date of Patent: April 14, 2020
    Assignee: Transitions Optical, Inc.
    Inventors: Ramaiahgari Reddy, Cory S. Brown, Alan Grubb, Meng He, Anil Kumar, Ruisong Xu
  • Publication number: 20170275534
    Abstract: The present invention relates to compounds that have ultraviolet light absorbing properties, and which can also have mesogenic properties. The present invention also relates to compositions that include one or more such compounds, and to articles of manufacture that include one or more such compounds, such as optical elements that include an optical substrate and a layer that includes at least one compound of the present invention.
    Type: Application
    Filed: September 21, 2015
    Publication date: September 28, 2017
    Inventors: Ramaiahgari REDDY, Cory S. BROWN, Alan GRUBB, Meng HE, Anil KUMAR, Ruisong XU
  • Publication number: 20170247399
    Abstract: The present invention generally relates to processes for the enzymatic production of a phosphinothricin product or precursor thereof from a nitrile-containing substrate.
    Type: Application
    Filed: May 15, 2017
    Publication date: August 31, 2017
    Applicant: Strategic Enzyme Applications, Inc.
    Inventors: Kim F. Albizati, Spiros Kambourakis, Alan Grubbs, Bennett C. Borer
  • Patent number: 9683001
    Abstract: The present invention generally relates to processes for the enzymatic production of a phosphinothricin product or precursor thereof from a nitrile-containing substrate.
    Type: Grant
    Filed: March 4, 2015
    Date of Patent: June 20, 2017
    Assignee: Stragegic Enzyme Applications, Inc.
    Inventors: Kim F. Albizati, Spiros Kambourakis, Alan Grubbs, Bennett C. Borer
  • Publication number: 20150239917
    Abstract: The present invention generally relates to processes for the enzymatic production of a phosphinothricin product or precursor thereof from a nitrile-containing substrate.
    Type: Application
    Filed: March 4, 2015
    Publication date: August 27, 2015
    Applicant: STRATEGIC ENZYME APPLICATIONS, INC.
    Inventors: Kim F. Albizati, Spiros Kambourakis, Alan Grubbs, Bennett C. Borer
  • Patent number: 8981142
    Abstract: The present invention generally relates to processes for the enzymatic production of a phosphinothricin product or precursor thereof from a nitrile-containing substrate.
    Type: Grant
    Filed: April 14, 2010
    Date of Patent: March 17, 2015
    Assignee: Strategic Enzyme Applications, Inc.
    Inventors: Kim F. Albizati, Spiros Kambourakis, Alan Grubbs, Bennett C. Borer
  • Publication number: 20130204031
    Abstract: The present invention generally relates to processes for the enzymatic production of a phosphinothricin product or precursor thereof from a nitrile-containing substrate.
    Type: Application
    Filed: April 14, 2010
    Publication date: August 8, 2013
    Applicant: STRATEGIC ENZYME APPLICATIONS, INC.
    Inventors: Kim F. Albizati, Spiros Kambourakis, Alan Grubbs, Bennett C. Borer
  • Publication number: 20120072638
    Abstract: Trapping and/or processing of read/write accesses to hardware devices represented to the host through a memory mapped space may be performed without knowledge of the processor's instruction set or semantics of the processor's instructions. A single step routine may be executed to recognize page faults occurring from read/write accesses to emulated memory pages and causing the guest to retry the operation on a single step buffer. The hypervisor may perform post-operation processing on the single step buffer after the guest retries and completes the read or write access. For example, on a read request, the single step routine may place the guest value in the single step buffer for reading by the guest on a retry operation. On a write request, the single step routine may direct the guest to retry the write operation into the single step buffer.
    Type: Application
    Filed: September 16, 2010
    Publication date: March 22, 2012
    Applicant: Unisys Corp.
    Inventors: J. Alan Grubb, John Landis, Bryan Thompson, James R. Hunter